» Articles » PMID: 25954300

Long Noncoding RNAs: a Potential Novel Class of Cancer Biomarkers

Overview
Journal Front Genet
Date 2015 May 9
PMID 25954300
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) are a novel class of RNA molecules defined as transcripts longer than 200 nucleotides that lack protein coding potential. They constitute a major, but still poorly characterized part of human transcriptome, however, evidence is growing that they are important regulatory molecules involved in various cellular processes. It is becoming increasingly clear that many lncRNAs are deregulated in cancer and some of them can be important drivers of malignant transformation. On the one hand, some lncRNAs can have highly specific expression in particular types of cancer making them a promising tool for diagnosis. The expression of other lncRNAs can correlate with different pathophysiological features of tumor growth and with patient survival, thus making them convenient biomarkers for prognosis. In this review we outline the current state of knowledge about the fast growing field of application of lncRNAs as tumor biomarkers.

Citing Articles

PCAT19: the role in cancer pathogenesis and beyond.

Hu H, Luo H, Deng Z Front Cell Dev Biol. 2025; 12:1435717.

PMID: 39744012 PMC: 11688190. DOI: 10.3389/fcell.2024.1435717.


The Role of Long Intergenic Noncoding RNA in Fetal Development.

Oguntoyinbo I, Goyal R Int J Mol Sci. 2024; 25(21).

PMID: 39519006 PMC: 11546696. DOI: 10.3390/ijms252111453.


LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.

Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K Heliyon. 2024; 10(18):e37527.

PMID: 39309878 PMC: 11415682. DOI: 10.1016/j.heliyon.2024.e37527.


Long non-coding RNA PVT1 regulates TGF-β and promotes the proliferation, migration and invasion of hypopharyngeal carcinoma FaDu cells.

Zhao Y, Zhao L, Li M, Meng Z, Wang S, Li J World J Surg Oncol. 2024; 22(1):254.

PMID: 39300515 PMC: 11414033. DOI: 10.1186/s12957-024-03536-w.


GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis.

Liu R, Wang J, Zhang L, Wang S, Li X, Liu Y BMC Cancer. 2024; 24(1):1126.

PMID: 39256686 PMC: 11385156. DOI: 10.1186/s12885-024-12845-y.


References
1.
Xu Z, Yu Q, Du Y, Yang L, Dong R, Huang L . Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013; 9(6):587-97. PMC: 3708039. DOI: 10.7150/ijbs.6339. View

2.
Jenjaroenpun P, Kremenska Y, Nair V, Kremenskoy M, Joseph B, Kurochkin I . Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing. PeerJ. 2013; 1:e201. PMC: 3828613. DOI: 10.7717/peerj.201. View

3.
Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J . A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012; 7(4):e35145. PMC: 3320879. DOI: 10.1371/journal.pone.0035145. View

4.
Xie H, Ma H, Zhou D . Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013; 2013:136106. PMC: 3674644. DOI: 10.1155/2013/136106. View

5.
Carninci P, Kasukawa T, Katayama S, Gough J, Frith M, Maeda N . The transcriptional landscape of the mammalian genome. Science. 2005; 309(5740):1559-63. DOI: 10.1126/science.1112014. View